Computational Modeling of Clinically Approved Alkylating Agents Against Epidermal and Fibroblast Growth Factor Receptors: A Step Toward Liver Cancer Therapeutics. Pjmcr. 2025;4(4):1970-1987. doi:10.64105/d0gq9a09